Silencing of HNRNPA1 or NCL in HCC cells using small RNA fragments (i.e., Aptamer BC15 for HNRNPA1 or AS1411 and AGRO100 for NCL) results in a potent reduction of cancer cell growth [198,199]. The gene discussed is HNRNPA1; the disease is hepatocellular carcinoma.